Mesenchymal chondrosarcoma is a rare tumor that is more common in young people; it is an uncommon type of chondrosarcoma with a poor prognosis. In two-thirds of cases, it affects the bone, especially the spine. However, parts of the body other than the skeletal system are occasionally involved. These rarer types have a worse prognosis, with a high likelihood of metastasis and death. Due to the possible misdiagnosis of mesenchymal chondrosarcoma, the integrated use of imaging, immunohistochemistry, and pathology can be helpful.
A 29-year-old female who received assisted reproductive therapy (IVF) in our
infertility clinic, at gestational age of 7w + 2d following embryo transfer,
presented with a favorable rise of β-hCG level with no detectable
gestational sac in the uterine cavity in the vaginal ultrasonogram. First dose
of MTX (78) with simultaneous β-hCG titration of 110,000 pg/mL was
administered. The patient underwent a second TVS in which a mass in favor of
molar ectopic pregnancy was reported. With the suspicion of a molar EP the
patient underwent explorative laparotomy. A 3x4 cm mass which was found adjacent
to the right ovary was resected. Final pathology report was compatible with
partial molar pregnancy. In the follow up period after surgical resection the
patient recovered completely without any recurrence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.